Discovery & Innovation

This is Part 1 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 2 and Part 3). Medical research and...

The need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed...

More than $2 trillion dollars a year are spent on treatments for CNS disorders. One in three people over 80 currently has Alzheimer’s disease. With...

The BRAIN Initiative sponsored by the NIH has pushed neuroscience and technology to center stage with President Obama supporting advancing...

The annual “Science Innovations” competition from The Scientist magazine uncovered a bonanza of interesting technologies that made their way into...

Drones are all over the news at the moment - are they really a science fiction notion soon to become reality? Tapping into the current frenzy...

Is there a way to quantify early drug discovery productivity to improve pharmaceutical innovation? Pharmaceutical innovation is dependent upon a...

Stem cells are being used to develop robust, reliable disease models that are advancing our understanding of underlying disease progression and...

How are stem cells advancing compound screening and analysis of drug-like properties? Stem cells are emerging as significant reagents in drug...

Imagine this: in a routine blood test, a doctor detects a biomarker that indicates a patient has early-stage pancreatic cancer. A therapeutic is...